{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T22:51:04Z","timestamp":1743029464336,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":52,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071644294"},{"type":"electronic","value":"9781071644300"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-1-0716-4430-0_2","type":"book-chapter","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T15:15:13Z","timestamp":1742310913000},"page":"57-70","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Xenogeneic Animal Models of Graft-Versus-Host Disease"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4909-686X","authenticated-orcid":false,"given":"Ronald","family":"Sluyter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9214-0742","authenticated-orcid":false,"given":"Chloe","family":"Sligar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0625-3183","authenticated-orcid":false,"given":"Amal","family":"Elhage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9861-7706","authenticated-orcid":false,"given":"Kang Min","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6242-3944","authenticated-orcid":false,"given":"Debbie","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"key":"2_CR1","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3324\/haematol.2021.279189","volume":"107","author":"D Niederwieser","year":"2022","unstructured":"Niederwieser D, Baldomero H, Bazuaye N, Bupp C, Chaudhri N, Corbacioglu S, Elhaddad A, Frutos C, Galeano S, Hamad N, Hamidieh AA, Hashmi S, Ho A, Horowitz MM, Iida M, Jaimovich G, Karduss A, Kodera Y, Kr\u00f6ger N, P\u00e9ffault de Latour R, Lee JW, Mart\u00ednez-Rol\u00f3n J, Pasquini MC, Passweg J, Paulson K, Seber A, Snowden JA, Srivastava A, Szer J, Weisdorf D, Worel N, Koh MBC, Aljurf M, Greinix H, Atsuta Y, Saber W (2022) One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors. Haematologica 107:1045\u20131053. https:\/\/doi.org\/10.3324\/haematol.2021.279189","journal-title":"Haematologica"},{"key":"2_CR2","doi-asserted-by":"publisher","first-page":"e573","DOI":"10.1016\/s2352-3026(19)30158-9","volume":"6","author":"R Shouval","year":"2019","unstructured":"Shouval R, Fein JA, Labopin M, Kr\u00f6ger N, Duarte RF, Bader P, Chabannon C, Kuball J, Basak GW, Dufour C, Galimard JE, Polge E, Lankester A, Montoto S, Snowden JA, Styczynski J, Yakoub-Agha I, Mohty M, Nagler A (2019) Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis. Lancet Haematol 6:e573\u2013e584. https:\/\/doi.org\/10.1016\/s2352-3026(19)30158-9","journal-title":"Lancet Haematol"},{"key":"2_CR3","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41571-020-0356-4","volume":"17","author":"BR Blazar","year":"2020","unstructured":"Blazar BR, Hill GR, Murphy WJ (2020) Dissecting the biology of allogeneic HSCT to enhance the GvT effect whilst minimizing GvHD. Nat Rev Clin Oncol 17:475\u2013492. https:\/\/doi.org\/10.1038\/s41571-020-0356-4","journal-title":"Nat Rev Clin Oncol"},{"key":"2_CR4","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1056\/NEJMra1609337","volume":"377","author":"R Zeiser","year":"2017","unstructured":"Zeiser R, Blazar BR (2017) Acute graft-versus-host disease \u2013 biologic process, prevention, and therapy. N Engl J Med 377:2167\u20132179. https:\/\/doi.org\/10.1056\/NEJMra1609337","journal-title":"N Engl J Med"},{"key":"2_CR5","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1056\/NEJMra1703472","volume":"377","author":"R Zeiser","year":"2017","unstructured":"Zeiser R, Blazar BR (2017) Pathophysiology of chronic graft-versus-host disease and therapeutic targets. N Engl J Med 377:2565\u20132579. https:\/\/doi.org\/10.1056\/NEJMra1703472","journal-title":"N Engl J Med"},{"key":"2_CR6","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1182\/hematology.2021000301","volume":"2021","author":"BK Hamilton","year":"2021","unstructured":"Hamilton BK (2021) Updates in chronic graft-versus-host disease. Hematology Am Soc Hematol Educ Program 2021:648\u2013654. https:\/\/doi.org\/10.1182\/hematology.2021000301","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2_CR7","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1182\/blood.2021012431","volume":"138","author":"R Zeiser","year":"2021","unstructured":"Zeiser R, Teshima T (2021) Nonclassical manifestations of acute GVHD. Blood 138:2165\u20132172. https:\/\/doi.org\/10.1182\/blood.2021012431","journal-title":"Blood"},{"key":"2_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/00007890-199507270-00011","volume":"60","author":"JS Sandhu","year":"1995","unstructured":"Sandhu JS, Gorczynski R, Shpitz B, Gallinger S, Nguyen HP, Hozumi N (1995) A human model of xenogeneic graft-versus-host disease in SCID mice engrafted with human peripheral blood lymphocytes. Transplantation 60:179\u2013184","journal-title":"Transplantation"},{"key":"2_CR9","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/291334a0","volume":"291","author":"M Kasai","year":"1981","unstructured":"Kasai M, Yoneda T, Habu S, Maruyama Y, Okumura K, Tokunaga T (1981) In vivo effect of anti-asialo GM1 antibody on natural killer activity. Nature 291:334\u2013335. https:\/\/doi.org\/10.1038\/291334a0","journal-title":"Nature"},{"key":"2_CR10","doi-asserted-by":"publisher","first-page":"10285","DOI":"10.1073\/pnas.93.19.10285","volume":"93","author":"T Blunt","year":"1996","unstructured":"Blunt T, Gell D, Fox M, Taccioli GE, Lehmann AR, Jackson SP, Jeggo PA (1996) Identification of a nonsense mutation in the carboxyl-terminal region of DNA-dependent protein kinase catalytic subunit in the scid mouse. Proc Natl Acad Sci USA 93:10285\u201310290. https:\/\/doi.org\/10.1073\/pnas.93.19.10285","journal-title":"Proc Natl Acad Sci USA"},{"key":"2_CR11","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/leu.2015.231","volume":"30","author":"TA Seldon","year":"2016","unstructured":"Seldon TA, Pryor R, Palkova A, Jones ML, Verma ND, Findova M, Braet K, Sheng Y, Fan Y, Zhou EY, Marks JD, Munro T, Mahler SM, Barnard RT, Fromm PD, Silveira PA, Elgundi Z, Ju X, Clark GJ, Bradstock KF, Munster DJ, Hart DN (2016) Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantation. Leukemia 30:692\u2013700. https:\/\/doi.org\/10.1038\/leu.2015.231","journal-title":"Leukemia"},{"key":"2_CR12","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1182\/blood-2002-10-3241","volume":"102","author":"RS van Rijn","year":"2003","unstructured":"van Rijn RS, Simonetti ER, Hagenbeek A, Hogenes MC, de Weger RA, Canninga-van Dijk MR, Weijer K, Spits H, Storm G, van Bloois L, Rijkers G, Martens AC, Ebeling SB (2003) A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2-\/- gammac-\/- double-mutant mice. Blood 102:2522\u20132531. https:\/\/doi.org\/10.1182\/blood-2002-10-3241","journal-title":"Blood"},{"key":"2_CR13","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/0092-8674(92)90029-c","volume":"68","author":"Y Shinkai","year":"1992","unstructured":"Shinkai Y, Rathbun G, Lam KP, Oltz EM, Stewart V, Mendelsohn M, Charron J, Datta M, Young F, Stall AM et al (1992) RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68:855\u2013867. https:\/\/doi.org\/10.1016\/0092-8674(92)90029-c","journal-title":"Cell"},{"key":"2_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/1074-7613(95)90047-0","volume":"2","author":"X Cao","year":"1995","unstructured":"Cao X, Shores EW, Hu-Li J, Anver MR, Kelsall BL, Russell SM, Drago J, Noguchi M, Grinberg A, Bloom ET et al (1995) Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 2:223\u2013238. https:\/\/doi.org\/10.1016\/1074-7613(95)90047-0","journal-title":"Immunity"},{"key":"2_CR15","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.exphem.2007.06.007","volume":"35","author":"B Nervi","year":"2007","unstructured":"Nervi B, Rettig MP, Ritchey JK, Wang HL, Bauer G, Walker J, Bonyhadi ML, Berenson RJ, Prior JL, Piwnica-Worms D, Nolta JA, DiPersio JF (2007) Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD\/SCID beta2mnull mice. Exp Hematol 35:1823\u20131838. https:\/\/doi.org\/10.1016\/j.exphem.2007.06.007","journal-title":"Exp Hematol"},{"key":"2_CR16","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/ni1527","volume":"8","author":"K Takenaka","year":"2007","unstructured":"Takenaka K, Prasolava TK, Wang JC, Mortin-Toth SM, Khalouei S, Gan OI, Dick JE, Danska JS (2007) Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat Immunol 8:1313\u20131323. https:\/\/doi.org\/10.1038\/ni1527","journal-title":"Nat Immunol"},{"key":"2_CR17","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.4049\/jimmunol.158.8.3578","volume":"158","author":"SW Christianson","year":"1997","unstructured":"Christianson SW, Greiner DL, Hesselton RA, Leif JH, Wagar EJ, Schweitzer IB, Rajan TV, Gott B, Roopenian DC, Shultz LD (1997) Enhanced human CD4+ T cell engraftment in beta2-microglobulin-deficient NOD-scid mice. J Immunol 158:3578\u20133586","journal-title":"J Immunol"},{"key":"2_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/00007890-200107150-00026","volume":"72","author":"T Berney","year":"2001","unstructured":"Berney T, Molano RD, Pileggi A, Cattan P, Li H, Ricordi C, Inverardi L (2001) Patterns of engraftment in different strains of immunodeficient mice reconstituted with human peripheral blood lymphocytes. Transplantation 72:133\u2013140. https:\/\/doi.org\/10.1097\/00007890-200107150-00026","journal-title":"Transplantation"},{"key":"2_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.723544","volume":"12","author":"NJ Hess","year":"2021","unstructured":"Hess NJ, Brown ME, Capitini CM (2021) GVHD pathogenesis, prevention and treatment: lessons from humanized mouse transplant models. Front Immunol 12:723544. https:\/\/doi.org\/10.3389\/fimmu.2021.723544","journal-title":"Front Immunol"},{"key":"2_CR20","doi-asserted-by":"publisher","first-page":"BSR20211986","DOI":"10.1042\/bsr20211986","volume":"42","author":"A Elhage","year":"2022","unstructured":"Elhage A, Sligar C, Cuthbertson P, Watson D, Sluyter R (2022) Insights into mechanisms of graft-versus-host disease through humanised mouse models. Biosci Rep 42:BSR20211986. https:\/\/doi.org\/10.1042\/bsr20211986","journal-title":"Biosci Rep"},{"key":"2_CR21","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1365-2249.2009.03933.x","volume":"157","author":"MA King","year":"2009","unstructured":"King MA, Covassin L, Brehm MA, Racki W, Pearson T, Leif J, Laning J, Fodor W, Foreman O, Burzenski L, Chase TH, Gott B, Rossini AA, Bortell R, Shultz LD, Greiner DL (2009) Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex. Clin Exp Immunol 157:104\u2013118. https:\/\/doi.org\/10.1111\/j.1365-2249.2009.03933.x","journal-title":"Clin Exp Immunol"},{"key":"2_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044219","volume":"7","author":"N Ali","year":"2012","unstructured":"Ali N, Flutter B, Sanchez Rodriguez R, Sharif-Paghaleh E, Barber LD, Lombardi G, Nestle FO (2012) Xenogeneic graft-versus-host-disease in NOD-scid IL-2R\u03b3null mice display a T-effector memory phenotype. PLoS One 7:e44219. https:\/\/doi.org\/10.1371\/journal.pone.0044219","journal-title":"PLoS One"},{"key":"2_CR23","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/bmt.2011.93","volume":"47","author":"J Gregoire-Gauthier","year":"2012","unstructured":"Gregoire-Gauthier J, Durrieu L, Duval A, Fontaine F, Dieng MM, Bourgey M, Patey-Mariaud de Serre N, Louis I, Haddad E (2012) Use of immunoglobulins in the prevention of GvHD in a xenogeneic NOD\/SCID\/\u03b3c- mouse model. Bone Marrow Transplant 47:439\u2013450. https:\/\/doi.org\/10.1038\/bmt.2011.93","journal-title":"Bone Marrow Transplant"},{"key":"2_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/cei.13005","volume":"190","author":"NJ Geraghty","year":"2017","unstructured":"Geraghty NJ, Belfiore L, Ly D, Adhikary SR, Fuller SJ, Varikatt W, Sanderson-Smith ML, Sluyter V, Alexander SI, Sluyter R, Watson D (2017) The P2X7 receptor antagonist Brilliant Blue G reduces serum human interferon-\u03b3 in a humanized mouse model of graft-versus-host disease. Clin Exp Immunol 190:79\u201395. https:\/\/doi.org\/10.1111\/cei.13005","journal-title":"Clin Exp Immunol"},{"key":"2_CR25","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1042\/cs20191086","volume":"134","author":"P Cuthbertson","year":"2020","unstructured":"Cuthbertson P, Adhikary SR, Geraghty NJ, Guy TV, Hadjiashrafi A, Fuller SJ, Ly D, Watson D, Sluyter R (2020) Increased P2X7 expression in the gastrointestinal tract and skin in a humanised mouse model of graft-versus-host disease. Clin Sci (Lond) 134:207\u2013223. https:\/\/doi.org\/10.1042\/cs20191086","journal-title":"Clin Sci (Lond)"},{"key":"2_CR26","doi-asserted-by":"publisher","first-page":"eabo0205","DOI":"10.1126\/scitranslmed.abo0205","volume":"15","author":"A Le Floc\u2019h","year":"2023","unstructured":"Le Floc\u2019h A, Nagashima K, Birchard D, Scott G, Ben LH, Ajithdoss D, Gayvert K, Romero Hernandez A, Herbin O, Tay A, Farrales P, Korgaonkar CK, Pan H, Shah S, Kamat V, Chatterjee I, Popke J, Oyejide A, Lim WK, Kim JH, Huang T, Franklin M, Olson W, Norton T, Perlee L, Yancopoulos GD, Murphy AJ, Sleeman MA, Orengo JM (2023) Blocking common \u03b3 chain cytokine signaling ameliorates T cell-mediated pathogenesis in disease models. Sci Transl Med 15:eabo0205. https:\/\/doi.org\/10.1126\/scitranslmed.abo0205","journal-title":"Sci Transl Med"},{"key":"2_CR27","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/imcb.12251","volume":"97","author":"NJ Geraghty","year":"2019","unstructured":"Geraghty NJ, Watson D, Sluyter R (2019) Pharmacological blockade of the CD39\/CD73 pathway but not adenosine receptors augments disease in a humanized mouse model of graft-versus-host disease. Immunol Cell Biol 97:597\u2013610. https:\/\/doi.org\/10.1111\/imcb.12251","journal-title":"Immunol Cell Biol"},{"key":"2_CR28","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/trf.12279","volume":"54","author":"M Hannon","year":"2014","unstructured":"Hannon M, Lechanteur C, Lucas S, Somja J, Seidel L, Belle L, Bruck F, Baudoux E, Giet O, Chantillon AM, Delvenne P, Drion P, Beguin Y, Humblet-Baron S, Baron F (2014) Infusion of clinical-grade enriched regulatory T cells delays experimental xenogeneic graft-versus-host disease. Transfusion 54:353\u2013363. https:\/\/doi.org\/10.1111\/trf.12279","journal-title":"Transfusion"},{"key":"2_CR29","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.3389\/fimmu.2018.01943","volume":"9","author":"G Ehx","year":"2018","unstructured":"Ehx G, Somja J, Warnatz HJ, Ritacco C, Hannon M, Delens L, Fransolet G, Delvenne P, Muller J, Beguin Y, Lehrach H, Belle L, Humblet-Baron S, Baron F (2018) Xenogeneic graft-versus-host disease in humanized NSG and NSG-HLA-A2\/HHD mice. Front Immunol 9:1943. https:\/\/doi.org\/10.3389\/fimmu.2018.01943","journal-title":"Front Immunol"},{"key":"2_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106085","volume":"26","author":"C Ritacco","year":"2023","unstructured":"Ritacco C, K\u00f6se MC, Courtois J, Canti L, Beguin C, Dubois S, Vandenhove B, Servais S, Caers J, Beguin Y, Ehx G, Baron F (2023) Post-transplant cyclophosphamide prevents xenogeneic graft-versus-host disease while depleting proliferating regulatory T cells. iScience 26:106085. https:\/\/doi.org\/10.1016\/j.isci.2023.106085","journal-title":"iScience"},{"key":"2_CR31","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.3390\/ijms25031775","volume":"25","author":"P Cuthbertson","year":"2024","unstructured":"Cuthbertson P, Button A, Sligar C, Elhage A, Vine KL, Watson D, Sluyter R (2024) Post-transplant cyclophosphamide combined with Brilliant Blue G reduces graft-versus-host disease without compromising graft-versus-leukaemia immunity in humanised mice. Int J Mol Sci 25:1775. https:\/\/doi.org\/10.3390\/ijms25031775","journal-title":"Int J Mol Sci"},{"key":"2_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1497","volume":"13","author":"C Sligar","year":"2024","unstructured":"Sligar C, Reilly E, Cuthbertson P, Vine KL, Bird KM, Elhage A, Alexander SI, Sluyter R, Watson D (2024) Graft-versus-leukaemia immunity is retained following treatment with post-transplant cyclophosphamide alone or combined with tocilizumab in humanised mice. Clin Transl Immunology 13:e1497. https:\/\/doi.org\/10.1002\/cti2.1497","journal-title":"Clin Transl Immunology"},{"key":"2_CR33","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1097\/TP.0b013e3181a5cb07","volume":"87","author":"R Ito","year":"2009","unstructured":"Ito R, Katano I, Kawai K, Hirata H, Ogura T, Kamisako T, Eto T, Ito M (2009) Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice. Transplantation 87:1654\u20131658. https:\/\/doi.org\/10.1097\/TP.0b013e3181a5cb07","journal-title":"Transplantation"},{"key":"2_CR34","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1182\/blood.V87.3.956.bloodjournal873956","volume":"87","author":"K Ohbo","year":"1996","unstructured":"Ohbo K, Suda T, Hashiyama M, Mantani A, Ikebe M, Miyakawa K, Moriyama M, Nakamura M, Katsuki M, Takahashi K, Yamamura K, Sugamura K (1996) Modulation of hematopoiesis in mice with a truncated mutant of the interleukin-2 receptor gamma chain. Blood 87:956\u2013967","journal-title":"Blood"},{"key":"2_CR35","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1111\/ajt.14116","volume":"17","author":"R Ito","year":"2017","unstructured":"Ito R, Katano I, Kawai K, Yagoto M, Takahashi T, Ka Y, Ogura T, Takahashi R, Ito M (2017) A novel xenogeneic graft-versus-host disease model for investigating the pathological role of human CD4+ or CD8+ T cells using immunodeficient NOG mice. Am J Transplant 17:1216\u20131228. https:\/\/doi.org\/10.1111\/ajt.14116","journal-title":"Am J Transplant"},{"key":"2_CR36","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1016\/j.bbmt.2018.04.016","volume":"24","author":"Y Kawasaki","year":"2018","unstructured":"Kawasaki Y, Sato K, Hayakawa H, Takayama N, Nakano H, Ito R, Mashima K, Oh I, Minakata D, Yamasaki R, Morita K, Ashizawa M, Yamamoto C, Hatano K, Fujiwara SI, Ohmine K, Muroi K, Kanda Y (2018) Comprehensive analysis of the activation and proliferation kinetics and effector functions of human lymphocytes, and antigen presentation capacity of antigen-presenting cells in xenogeneic graft-versus-host disease. Biol Blood Marrow Transplant 24:1563\u20131574. https:\/\/doi.org\/10.1016\/j.bbmt.2018.04.016","journal-title":"Biol Blood Marrow Transplant"},{"key":"2_CR37","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.4049\/jimmunol.1402785","volume":"194","author":"K Ohnuma","year":"2015","unstructured":"Ohnuma K, Hatano R, Aune TM, Otsuka H, Iwata S, Dang NH, Yamada T, Morimoto C (2015) Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes. J Immunol 194:3697\u20133712. https:\/\/doi.org\/10.4049\/jimmunol.1402785","journal-title":"J Immunol"},{"key":"2_CR38","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/bjh.12378","volume":"162","author":"R Hatano","year":"2013","unstructured":"Hatano R, Ohnuma K, Yamamoto J, Dang NH, Yamada T, Morimoto C (2013) Prevention of acute graft-versus-host disease by humanized anti-CD26 monoclonal antibody. Br J Haematol 162:263\u2013277. https:\/\/doi.org\/10.1111\/bjh.12378","journal-title":"Br J Haematol"},{"key":"2_CR39","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/jop.13258","volume":"51","author":"Q Jiang","year":"2022","unstructured":"Jiang Q, Yong X, Liu Z, Zhou Y, Mei G, Chen Q, Wu T, Tao R (2022) The oral histopathological and immunological characteristics of a xenogeneic mouse chronic graft-versus-host disease model. J Oral Pathol Med 51:369\u2013378. https:\/\/doi.org\/10.1111\/jop.13258","journal-title":"J Oral Pathol Med"},{"key":"2_CR40","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.2147\/jir.S323054","volume":"14","author":"Y Gao","year":"2021","unstructured":"Gao Y, Li W, Bu X, Xu Y, Cai S, Zhong J, Du M, Sun H, Huang L, He Y, Hu X, Liu Q, Jin H, Wang Q, Ping B (2021) Human amniotic mesenchymal stem cells inhibit aGVHD by regulating balance of Treg and T effector cells. J Inflamm Res 14:3985\u20133999. https:\/\/doi.org\/10.2147\/jir.S323054","journal-title":"J Inflamm Res"},{"key":"2_CR41","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/cei.12121","volume":"173","author":"SM B\u00fcchner","year":"2013","unstructured":"B\u00fcchner SM, Sliva K, Bonig H, V\u00f6lker I, Waibler Z, Kirberg J, Schnierle BS (2013) Delayed onset of graft-versus-host disease in immunodeficent human leucocyte antigen-DQ8 transgenic, murine major histocompatibility complex class II-deficient mice repopulated by human peripheral blood mononuclear cells. Clin Exp Immunol 173:355\u2013364. https:\/\/doi.org\/10.1111\/cei.12121","journal-title":"Clin Exp Immunol"},{"key":"2_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044664","volume":"7","author":"MB Greenblatt","year":"2012","unstructured":"Greenblatt MB, Vrbanac V, Tivey T, Tsang K, Tager AM, Aliprantis AO (2012) Graft versus host disease in the bone marrow, liver and thymus humanized mouse model. PLoS One 7:e44664. https:\/\/doi.org\/10.1371\/journal.pone.0044664","journal-title":"PLoS One"},{"key":"2_CR43","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1038\/nm1431","volume":"12","author":"MW Melkus","year":"2006","unstructured":"Melkus MW, Estes JD, Padgett-Thomas A, Gatlin J, Denton PW, Othieno FA, Wege AK, Haase AT, Garcia JV (2006) Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med 12:1316\u20131322. https:\/\/doi.org\/10.1038\/nm1431","journal-title":"Nat Med"},{"key":"2_CR44","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/tp.0000000000003047","volume":"104","author":"S M\u00e9noret","year":"2020","unstructured":"M\u00e9noret S, Ouisse LH, Tesson L, Remy S, Usal C, Guiffes A, Chenouard V, Royer PJ, Evanno G, Vanhove B, Piaggio E, Anegon I (2020) In vivo analysis of human immune responses in immunodeficient rats. Transplantation 104:715\u2013723. https:\/\/doi.org\/10.1097\/tp.0000000000003047","journal-title":"Transplantation"},{"key":"2_CR45","first-page":"246","volume":"69","author":"JL Caswell","year":"2005","unstructured":"Caswell JL, Yager JA (2005) Graft-versus-host disease in severe combined immunodeficiency\/beige mice administered canine leukocytes. Can J Vet Res 69:246\u2013252","journal-title":"Can J Vet Res"},{"key":"2_CR46","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jcyt.2012.09.003","volume":"15","author":"F Bruck","year":"2013","unstructured":"Bruck F, Belle L, Lechanteur C, de Leval L, Hannon M, Dubois S, Castermans E, Humblet-Baron S, Rahmouni S, Beguin Y, Briquet A, Baron F (2013) Impact of bone marrow-derived mesenchymal stromal cells on experimental xenogeneic graft-versus-host disease. Cytotherapy 15:267\u2013279. https:\/\/doi.org\/10.1016\/j.jcyt.2012.09.003","journal-title":"Cytotherapy"},{"key":"2_CR47","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2017.1314425","volume":"6","author":"G Ehx","year":"2017","unstructured":"Ehx G, Fransolet G, de Leval L, D\u2019Hondt S, Lucas S, Hannon M, Delens L, Dubois S, Drion P, Beguin Y, Humblet-Baron S, Baron F (2017) Azacytidine prevents experimental xenogeneic graft-versus-host disease without abrogating graft-versus-leukemia effects. Onco Targets Ther 6:e1314425. https:\/\/doi.org\/10.1080\/2162402x.2017.1314425","journal-title":"Onco Targets Ther"},{"key":"2_CR48","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.vetimm.2013.11.007","volume":"157","author":"JB Foote","year":"2014","unstructured":"Foote JB, Kabir FM, Graff EC, Cattley RC, DeInnocentes P, Smith BF, Bird RC (2014) Engraftment of canine peripheral blood lymphocytes into nonobese diabetic-severe combined immune deficient IL-2R common gamma chain null mice. Vet Immunol Immunopathol 157:131\u2013141. https:\/\/doi.org\/10.1016\/j.vetimm.2013.11.007","journal-title":"Vet Immunol Immunopathol"},{"key":"2_CR49","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/jlb.5a1019-501rr","volume":"111","author":"CJ Kim","year":"2022","unstructured":"Kim CJ, Park SC, Lee SH, Lim YJ, Yoon M, Park JG, Baek YB, Cho KO, Hong JW, Shin DJ, Kim SK (2022) Safety analysis of ex vivo-expanded canine natural killer cells in a xenogeneic mouse model of graft-versus-host disease. J Leukoc Biol 111:439\u2013450. https:\/\/doi.org\/10.1002\/jlb.5a1019-501rr","journal-title":"J Leukoc Biol"},{"key":"2_CR50","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.clim.2007.11.001","volume":"126","author":"M King","year":"2008","unstructured":"King M, Pearson T, Shultz LD, Leif J, Bottino R, Trucco M, Atkinson MA, Wasserfall C, Herold KC, Woodland RT, Schmidt MR, Woda BA, Thompson MJ, Rossini AA, Greiner DL (2008) A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene. Clin Immunol 126:303\u2013314. https:\/\/doi.org\/10.1016\/j.clim.2007.11.001","journal-title":"Clin Immunol"},{"key":"2_CR51","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/s0165-2427(99)00065-3","volume":"70","author":"C H\u00f6lscher","year":"1999","unstructured":"H\u00f6lscher C, Hasch G, Joswig N, Stauffer U, M\u00fcller U, Mossmann H (1999) Long term substitution and specific immune responses after transfer of bovine peripheral blood lymphocytes into severe combined immunodeficient mice. Vet Immunol Immunopathol 70:67\u201383. https:\/\/doi.org\/10.1016\/s0165-2427(99)00065-3","journal-title":"Vet Immunol Immunopathol"},{"key":"2_CR52","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.3390\/ani11102962","volume":"11","author":"C Leeth","year":"2021","unstructured":"Leeth C, Adkins J, Hay A, Bogers S, Potter A, Witonsky S, Zhu J (2021) Engrafting horse immune cells into mouse hosts for the study of the acute equine immune responses. Animals (Basel) 11:2962. https:\/\/doi.org\/10.3390\/ani11102962","journal-title":"Animals (Basel)"}],"container-title":["Methods in Molecular Biology","Graft-Versus-Host Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4430-0_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T15:15:19Z","timestamp":1742310919000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4430-0_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9781071644294","9781071644300"],"references-count":52,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4430-0_2","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"19 March 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}